Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis
出版年份 2018 全文链接
标题
Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis
作者
关键词
-
出版物
World Psychiatry
Volume 17, Issue 3, Pages 330-340
出版商
Wiley
发表日期
2018-09-07
DOI
10.1002/wps.20579
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use
- (2017) Maren Carbon et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Comparison of Ziprasidone and Risperidone in the Long-Term Treatment of Schizophrenia: A 44-Week, Double-Blind, Continuation Study
- (2017) Donald E Addington et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.
- (2016) Stefan Leucht et al. SCHIZOPHRENIA BULLETIN
- Metabolic syndrome and drug discontinuation in schizophrenia: a randomized trial comparing aripiprazole olanzapine and haloperidol
- (2015) A. Parabiaghi et al. ACTA PSYCHIATRICA SCANDINAVICA
- Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management
- (2015) P. Manu et al. ACTA PSYCHIATRICA SCANDINAVICA
- Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies
- (2015) Pál Czobor et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia
- (2015) Dieter Naber et al. SCHIZOPHRENIA RESEARCH
- Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia
- (2014) Joseph P. McEvoy et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incidence of Tardive Dyskinesia in Older Adult Patients Treated With Olanzapine or Conventional Antipsychotics
- (2014) Bruce J. Kinon et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Treatment of neurolept-induced tardive dyskinesia
- (2013) Stacey Jankelowitz Neuropsychiatric Disease and Treatment
- Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs
- (2012) Michael J. Peluso et al. BRITISH JOURNAL OF PSYCHIATRY
- Long-term safety and tolerability of lurasidone in schizophrenia
- (2012) Leslie Citrome et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial
- (2011) Ragy R. Girgis et al. BRITISH JOURNAL OF PSYCHIATRY
- Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: A pragmatic, randomized trial
- (2011) E. Johnsen et al. EUROPEAN PSYCHIATRY
- Asenapine Versus Olanzapine in People With Persistent Negative Symptoms of Schizophrenia
- (2011) Robert W. Buchanan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head–head comparisons
- (2011) Peter M Haddad et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Pilot, 15-month, randomised effectiveness trial of Risperidone long-acting injection (RLAI) versus oral atypical antipsychotic agents (AAP) in persons with bipolar disorder
- (2010) K. N. Roy Chengappa et al. ACTA NEUROPSYCHIATRICA
- Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study
- (2010) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Incidence of Tardive Dyskinesia With Atypical Versus Conventional Antipsychotic Medications
- (2010) Scott W. Woods et al. JOURNAL OF CLINICAL PSYCHIATRY
- Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial
- (2010) Wolfgang Gaebel et al. NEUROPSYCHOPHARMACOLOGY
- Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
- (2010) J. Schoemaker et al. PHARMACOPSYCHIATRY
- A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia
- (2010) Herbert Y. Meltzer et al. PSYCHIATRY RESEARCH
- How to read and understand and use systematic reviews and meta-analyses
- (2009) S. Leucht et al. ACTA PSYCHIATRICA SCANDINAVICA
- Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis
- (2009) Manuel J. Cuesta et al. BRITISH JOURNAL OF PSYCHIATRY
- Olanzapine compared to quetiapine in adolescents with a first psychotic episode
- (2009) Celso Arango et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol
- (2009) Steven G. Potkin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia
- (2009) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Extrapyramidal side-effects of antipsychotics in a randomised trial
- (2008) Del D. Miller et al. BRITISH JOURNAL OF PSYCHIATRY
- Metoclopramide, an Increasingly Recognized Cause of Tardive Dyskinesia
- (2008) Christopher Kenney et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started